Whistler Conference Centre Floorplan

Registered Attendees


Registered attendees (and speakers, organizers, etc.) will have access to the following items from their Account page:

  • Abstracts from speakers and poster sessions, including the joint meeting abstracts, available 30 days prior to the meeting (You can edit your own abstract from My Account page as well)

    NOTE: Abstract authors/submitters may choose to not have their abstract available online and in the secure mobile app until a week before the meeting.

  • Full participant list, including joint meeting participants
  • Printable Invoices and Invitation Letters
  • Scholarship Information
  • Lodging Information

Login to My Account page

This meeting took place in 2012



For a complete list of the meetings for the upcoming/current season, see our meeting list, or search for a meeting.

NF-kappaB Signaling and Biology: From Bench to Bedside (X1)


Organizer(s) Michael Karin and Hao Wu
March 18—23, 2012
Whistler Conference Centre • Whistler, British Columbia Canada
Abstract Deadline: Nov 16, 2011
Late Abstract Deadline: Dec 20, 2011
Scholarship Deadline: Nov 16, 2011
Early Registration Deadline: Jan 18, 2012

Sponsored by Onyx Pharmaceuticals, Inc.

Joint Meeting: Ubiquitin Signaling (X2)

Summary of Meeting:
The regulation and function of NF-kB have captivated molecular and cellular biologists, as well as immunologists, pathologists and drug developers for many years. Studies of NF-kB and its regulation have taught us many fundamental lessons and principals in basic biological sciences as well as in biomedicine. Although rapidly reaching maturity, with 25 years since its discovery, the NF-kB field remains vibrant and fertile, and never ceases to amaze with new groundbreaking discoveries. The Keystone Symposia meeting on NF-kB Signaling and Biology: From Bench to Bedside will cover the basic biochemistry of NF-kB signaling; how NF-kkB accomplishes its main job as a transcription factor; the roles of the NF-kB system in immunity and inflammation; how NF-kB controls cell death, survival and metabolism; and how all of these functions go awry during disease development – something that we have learned both from studies of genetically altered mice and from studies of human genetic defects and pathology. Finally, this meeting will teach us how we might fix and cure these problems through the pharmacological targeting of the NF-kB system. Opportunities for interdisciplinary interactions will be significantly enhanced by the concurrent meeting on Ubiquitin Signaling, which will share a keynote address and three plenary sessions with this meeting.

View Scholarships/Awards
No registration fees are used to fund entertainment or alcohol at this conference

Conference Program    Print  |   View meeting in 12 hr (am/pm) time


SUNDAY, MARCH 18

15:00—19:30
Registration

Grand Foyer
18:15—19:15
Refreshments

Grand Foyer
19:15—21:30
Welcome and Keynote Session (Joint)
Meeting has ended...abstracts no longer viewable online.

Sea to Sky B/C
* Michael Karin, University of California, San Diego, USA

David Baltimore, California Institute of Technology, USA
25 Years of the NF-kappaB Pathway

* Ivan Dikic, Goethe University Medical School, Germany

Aaron J. Ciechanover, Technion-Israel Institute of Technology, Israel
The Ubiquitin Proteolytic System: From Basic Mechanisms through Human Diseases and on to Drug Targeting


MONDAY, MARCH 19

07:00—08:00
Breakfast

Sea to Sky A
08:00—11:15
Ubiquitin-Dependent Signaling in NF-kappaB Activation (Joint)
Meeting has ended...abstracts no longer viewable online.

Sea to Sky B/C
* Claudio A. P. Joazeiro, The Scripps Research Institute, USA

* Henning Walczak, University College London, Cancer Institute, UK

Zhijian James Chen, University of Texas Southwestern Medical Center, USA
Ubiquitin Signaling in the RIG-I Antiviral Pathway

Hao Wu, Harvard Medical School, Boston Children's Hospital, USA
Structural and Functional Analyses of NF-kappaB and Cell Death Signaling

Domagoj Vucic, Genentech, Inc., USA
Short Talk: IAP Antagonists and TNF Receptors Differentially Regulate C-IAP Ubiquitin Ligase Activity

Ivan Dikic, Goethe University Medical School, Germany
Ubiquitin Networks in Regulation of NF-kappB Activation

Kazuhiro Iwai, Osaka University, Japan
Linear Polyubiquitination: A Crucial Regulator of NF-kappaB Signaling

Katrin E. Rittinger, Francis Crick Institute, UK
Short Talk: Mechanism of Linear Ubiquitin Chain Formation by the E3 Ligase Ccomplex LUBAC

09:20—09:40
Coffee Break

Grand Foyer
11:15—13:00
Poster Setup

Sea to Sky A
11:15
On Own for Lunch and Recreation

13:00—22:00
Poster Viewing

Sea to Sky A
16:30—17:00
Coffee Available

Grand Foyer
17:00—19:00
NF-kappaB and Transcription
Meeting has ended...abstracts no longer viewable online.

Sea to Sky C
* Thomas D. Gilmore, Boston University, USA

Alexander Hoffmann, University of California, Los Angeles, USA
NF-kappaB Functions within the Pathogen-Responsive Gene Regulatory Network

Stephen T. Smale, University of California, Los Angeles, USA
Transcriptional Specificity of an NF-kappaB Response

Ruaidhrí John Carmody, University College Cork, Ireland
Short Talk: De-Ubiquitination of NF-kappaB by Ubiquitin-Specific Protease-7 Promotes Transcription

Sulakshana P. Mukherjee, University of California, San Diego, USA
Short Talk: Insights into the RelA:CBP Interaction in Transcription Regulation

Matthew E. Pipkin, The Scripps Research Institute, USA
Short Talk: NFAT Transcription Factors Control Transcriptional Elongation in Memory CD8 T Cells


Following Session is for Ubiquitin Signaling (X2)

17:00—19:00
Ubiquitin Conjugation/Deconjugation Machineries
Meeting has ended...abstracts no longer viewable online.

Sea to Sky B
* Scott D. Emr, Cornell University, USA

* Jon Huibregtse, University of Texas at Austin, USA

Brenda A. Schulman, Max Planck Institute of Biochemistry, Germany
Structural Biology of E3 Ubiquitin Ligase Enzymes

Nicolas H. Thomä, Friedrich Miescher Institute for Biomedical Research, Switzerland
Short Talk: CRL4CSA/DDB2 Ubiquitin Ligase Architecture, Targeting to Chromatin and Cop9 Signalosome Mediated Regulation

Claudio A. P. Joazeiro, The Scripps Research Institute, USA
Listerin/Ltn1, an E3 Ligase Implicated in Neurodegeneration, Mediates a Novel Pathway of Cytoplasmic Protein Quality Control

Keith D. Wilkinson, Emory University, USA
Roles of the BAP1 Deubiquitinating Enzyme in Tumor Suppression

19:00—20:00
Social Hour with Lite Bites

Sea to Sky A
19:30—22:00
Poster Session 1

Sea to Sky A

TUESDAY, MARCH 20

07:00—08:00
Breakfast

Sea to Sky A
08:00—11:15
Innate and Adaptive Immunity and Ub-Dependent Signaling (Joint)
Meeting has ended...abstracts no longer viewable online.

Sea to Sky B/C
* J. Wade Harper, Harvard Medical School, USA

* Hao Wu, Harvard Medical School, Boston Children's Hospital, USA

Margot Thome, University of Lausanne, Switzerland
Role of the MALT1 Protease Activity in Adaptive Immunity and Lymphoma

Sarah Spiegel, Virginia Commonwealth University, USA
Regulation of RING E3 Ubiquitin Ligases by Sphingosine-1-Phosphate

Kristopher Clark, University of Dundee, UK
Short Talk: Cross-Talk within the IkappaB Kinase Family is Required to Limit NF-kappaB Signaling and Prevent Autoimmunity

Michael Karin, University of California, San Diego, USA
Ub Cascades in Innate Immunity

Vishva M. Dixit, Genentech, Inc., USA
Regulation of Pro-Inflammatory Receptor Signaling by Ubiquitin Hydrolases

Henning Walczak, University College London, Cancer Institute, UK
Short Talk: Linear Ubiquitination in Cell Death, Inflammation and Immunity

09:20—09:40
Coffee Break

Grand Foyer
11:15—13:00
Poster Setup

Sea to Sky A
11:15
On Own for Lunch and Recreation

13:00—22:00
Poster Viewing

Sea to Sky A
14:30—16:30
Workshop 1: NF-kappaB in Inflammation and Immunity

Sea to Sky C
* Manolis Pasparakis, University of Cologne, Germany

Dirk Brenner, Luxembourg Institute of Health, Luxembourg
MALT1 is Indispensable for an Inflammatory Th17 Cell Response

Thomas D. Gilmore, Boston University, USA
Evolutionary Origins of NF-kappaB Signaling

Christopher C. Goodnow, Garvan Institute of Medical Research, Australia
CARD11 Lymphoma Mutations Switch Self-Antigen Induced B Cell Death into Growth

Marie Anne O'Donnell, Rockefeller, USA
CASPASE 8 is a Dexterous Killer with a Heart

Michael J. May, University of Pennsylvania, USA
A Novel Role for cIAPs in IkappaBepsilon Degradation

Fabrice Agou, Institut Pasteur, France
Two-Sided Ubiquitin Binding Explains the EDA-ID-Related Mutations of NEMO ZF

Steven C. Ley, Francis Crick Institute, UK
Regulation of Immune Responses by IKK-Induced NF-kappaB1 p105 Proteolysis

Carolyn Gray, University of Pennsylvania, USA
A Role for NEMO in the Non-Canonical NF-kappaB Signaling Pathway

16:30—17:00
Coffee Available

Grand Foyer
17:00—19:00
NF-kappaB in Inflammation and Immunity
Meeting has ended...abstracts no longer viewable online.

Sea to Sky C
* Alexander Hoffmann, University of California, Los Angeles, USA

Takashi Fujita, Institute for Virus Research, Kyoto University, Japan
Antiviral Innate Immunity: Control of Interferon Production

Paulina A. Bartuzi, University Medical Center Groningen, Netherlands
Short Talk: Hepatic Depletion of Commd1 Ameliorates Liver Inflammation in a Mouse Model of Non-Alcoholic Steatohepatitis

Steve D. Gerondakis, Monash University, Australia
Short Talk: c-Rel Controls Multiple Steps in the Development of Thymic CD4 Regulatory T Cells


Following Session is for Ubiquitin Signaling (X2)

17:00—19:00
Ubiquitin Chains and Ubiquitin-Binding Domains (UBDs)
Meeting has ended...abstracts no longer viewable online.

Sea to Sky B
* Keith D. Wilkinson, Emory University, USA

* Eilika Weber-Ban, ETH Zürich, Switzerland

Kay Hofmann, University of Cologne, Germany
Bioinformatical Discovery and Characterization of Ubiquitin-Binding Domains

Michael Rape, University of California, Berkeley, USA
Function and Assembly of Lysine 11-Linked Ubiquitin Chains

Scott D. Emr, Cornell University, USA
Ubiquitin-Mediated Endocytosis and Down-Regulation of PM Proteins

Andreas Ernst, University of Toronto, Canada
Short Talk: A General Strategy to Generate Inhibitors of the Ubiquitin System

19:00—20:00
Social Hour with Lite Bites

Sea to Sky A
19:30—22:00
Poster Session 2

Sea to Sky A

WEDNESDAY, MARCH 21

07:00—08:00
Breakfast

Sea to Sky A
08:00—11:30
Cell Death Signaling and Its Regulation by Ubiquitin and NF-kappaB
Meeting has ended...abstracts no longer viewable online.

Sea to Sky C
* Domagoj Vucic, Genentech, Inc., USA

Francis Ka-Ming Chan, University of Massachusetts Medical School, USA
Regulation of Cell Death and Cell Survival by the RIP Kinases

Ingrid E. Wertz, Genentech, Inc., USA
Molecular Mechanisms of NF-kappaB Regulation by the Ubiquitin Editing Enzyme A20

Genhong Cheng, University of California, Los Angeles, USA
TRAF3 at the Crossroads of Antiviral and Inflammatory Responses

Zheng gang Liu, NCI, National Institutes of Health, USA
Understanding the Regulation of TNF-Induced Cell Death

Andrew Oberst, University of Washington, USA
Short Talk: Cooperation of FADD, Caspase-8, and FLIP is Required to Prevent RIPK3-Dependent Programmed Necrosis during Embryonic Development

Anning Lin, Shanghai Institute of Biochemistry and Cell Biology, China
Short Talk: Novel Signaling by the IKK Complex

Seda Çöl Arslan, Max Delbrück Center for Molecular Medicine, Germany
Short Talk: TAK1-RIP1 Interplay Determines the Prevalence of TNFalpha-Induced Programmed Necrosis over Apoptosis


Following Session is for Ubiquitin Signaling (X2)

08:00—11:15
Ubiquitin Signaling and Diseases
Meeting has ended...abstracts no longer viewable online.

Sea to Sky B
* Raymond J. Deshaies, Amgen, USA

* Mary C. Dasso, NICHD, National Institutes of Health, USA

Karen H. Vousden, Crick Institute, UK
Ubiquitin Signaling in the Regulation of p53

Agata Smogorzewska, Rockefeller University, USA
Ubiquitin Signaling in DNA Damage and Repair

Mads Daugaard, Vancouver Prostate Centre, Canada
Short Talk: The Hace1 E3 Ligase Blocks NADPH Oxidase Generation of Superoxide by Targeting Rac1 for Proteasomal Degradation

Pier Paolo Di Fiore, FIRC Institute of Molecular Oncology, Italy
Ubiquitin Pathways in Stem Cells

Judith Frydman, Stanford University, USA
Protein Aggregation and Neurodegeneration

Andreas Martin, University of California, Berkeley, USA
Short Talk: Complete Subunit Architecture of the 26S Proteasome Reveals Mechanisms of Ubiquitin-Dependent Substrate Degradation

09:20—09:40
Coffee Break

Grand Foyer
11:30—13:00
Poster Setup

Sea to Sky A
11:30
On Own for Lunch and Recreation

13:00—22:00
Poster Viewing

Sea to Sky A

Following Session is for Ubiquitin Signaling (X2)

13:30—15:00
Workshop 1: Novel Techniques to Track Ub Signals

Sea to Sky B
* Steven P. Gygi, Harvard Medical School, USA

* Ingrid E. Wertz, Genentech, Inc., USA

Eric J. Bennett, University of California, San Diego, USA
Monitoring Proteome Fidelity through Quantitative Analysis of Endogenous Ubiquitin Targets

Bradley B. Brasher, Boston Biochem, Inc., USA
Non-Hydrolyzable Polyubiquitin Chains: Development and Characterization of New Reagents for Signal Transduction Studies

Arno F. Alpi, University of Dundee, UK
Regulation of Cullin Neddylation by the Ariadne Subfamily of RING-in-between-RING E3 Ubiquitin Ligases

Simon Bekker-Jensen, University of Copenhagen, Denmark
Ubiquitin-Dependent Regulation of PAF15 Promotes Cellular Responses to Replication Blocks

Fumiyo Ikeda, IMBA - Institute of Molecular Biotechnology, Austria
Sharpin-Dependent Linear-Ubiquitination is Required for Cell Survival Pathway


Following Session is for Ubiquitin Signaling (X2)

15:00—16:30
Workshop 2: Disease Models and Novel Therapies

Sea to Sky B
* Karen H. Vousden, Crick Institute, UK

* Teresa Soucy, Millennium Pharmaceuticals, Inc., USA

Valentina Perissi, Boston University School of Medicine, USA
A Protective Strategy against Hyper-Inflammatory Responses Requiring GPS2 Inhibition of TRAF2 Enzymatic Activity

Koraljka Husnjak, Institute of Biochemistry II, Germany
Elucidating the Role of Proteasomal Ubiquitin Receptor Rpn13 in Growth and Development

Lynn Boyden, Yale University School of Medicine, USA
Mutations in Kelch-Like 3 and Cullin 3 Implicate Ubiquitination in Regulation of Electrolyte Homeostasis and Blood Pressure

Mads Gyrd-Hansen, University of Oxford, UK
XIAP Ubiquitylates RIPK2 and Recruits LUBAC to Regulate Innate Immune Signaling

Marene Landstrom, Umeå University, Sweden
The Molecular Mechanisms which Determines how TGF-beta Can Act as a Tumor Promoter

16:30—17:00
Coffee Available

Grand Foyer
17:00—19:15
NF-kappaB and Disease
Meeting has ended...abstracts no longer viewable online.

Sea to Sky C
* Alain Israël, Institut Pasteur, France

Yinon M. Ben-Neriah, Hebrew University, Hadassah Medical School, Israel
NF-kappaB in Cancer

Manolis Pasparakis, University of Cologne, Germany
IKK/NF-kappaB Signaling in Epithelial Homeostasis and Inflammation

Jean-Laurent Casanova, Rockefeller University, USA
Life-Threatening Infectious Diseases of Childhood: Single-Gene Inborn Errors of Immunity?

Ethel Cesarman, Weill Cornell Medical College, USA
Short Talk: Central Role of vFLIP-Induced NF-kappaB in the Pathobiology of KSHV-Associated Malignancies

Vasant Chellappa, Massachusetts General Hospital, USA
Short Talk: Somatic Mutations of RIPK4/PKK Drive NF-kappaB Dependent Cancers while Germline Variants Compromise NF-kappaB Signaling in an Inherited Syndrome Involving Defective Epidermal Differentiation


Following Session is for Ubiquitin Signaling (X2)

17:00—19:00
Proteome Analysis of Ub System
Meeting has ended...abstracts no longer viewable online.

Sea to Sky B
* Brenda A. Schulman, Max Planck Institute of Biochemistry, Germany

* Pier Paolo Di Fiore, FIRC Institute of Molecular Oncology, Italy

Lan Huang, University of California, Irvine, USA
Understanding the Ubiquitin-Proteasome System by Probing Protein-Protein Interactions

J. Wade Harper, Harvard Medical School, USA
Proteomic Exploration of the Ubiquitin System

Steven P. Gygi, Harvard Medical School, USA
Analyzing the Ubiquitin-Modified Proteome

Thibault Mayor, University of British Columbia, Canada
Short Talk: Systems-Wide Analysis Reveals that Low Abundant Disordered Proteins are Prone to Ubiquitylation after Misfolding Stress

19:15—20:00
Social Hour with Lite Bites

Sea to Sky A
19:30—22:00
Poster Session 3

Sea to Sky A

THURSDAY, MARCH 22

07:00—08:00
Breakfast

Sea to Sky A
08:00—11:15
Ubiquitin-Dependent Signaling to NF-kappaB in Disease and Therapy (Joint)
Meeting has ended...abstracts no longer viewable online.

Sea to Sky B/C
* Michael Rape, University of California, Berkeley, USA

Raymond J. Deshaies, Amgen, USA
Prospecting for Drug Targets in the Ubiquitin-Proteasome System

Teresa Soucy, Millennium Pharmaceuticals, Inc., USA
Mechanism-Based E1 Inhibitors Offer New Insights into Ubiquitin-Like Protein Conjugation

Daniel Krappmann, Helmholtz Zentrum München, Germany
Short Talk: Targeting the NEMO-Ubiquitin Interface with Small Molecules - New Strategy for the Design of Pharmacological NF-kappaB Inhibitors

Alain Israël, Institut Pasteur, France
Human Pathology Associated with Deficiency in HOIL-1, One of the Components of the LUBAC Ubiquitin Ligase Complex

Philip Cohen, University of Dundee, UK
Novel Cross-Talk within the IKK Family Controls Signaling to NF-kappaB

Neal Silverman, University of Massachusetts Medical School, USA
Short Talk: Caspase Mediated Cleavage, IAP Binding and Ubiquitination Drive Drosophila NF-kappaB Signaling

09:00—09:20
Coffee Break

Grand Foyer
11:00
On Own for Lunch and Recreation

14:30—16:30
Workshop 2: NF-kappaB in Cancer and Other Diseases

Sea to Sky C
* Francis Ka-Ming Chan, University of Massachusetts Medical School, USA

Bernd Baumann, University of Ulm, Germany
beta-Cell Specific Changes in IKK/NF-kappaB Signaling Interfere with beta-Cell Homeostasis and Result in Diabetes-Like Phenotypes

Katy Billot, Institut Cochin INSERM U1016, France
RelB Inhibits Cell Proliferation and Tumor Growth through p53 Transcriptional Activation

Brent Cameron, Case Western Reserve University, USA
Loss of IRAK4 Function Alters Microglial Response and Enhances Clearance of Abeta from the Brain in an Alzheimer’s Disease Mouse Model

Carter Van Waes, NIDCD, National Institutes of Health, USA
Novel c-REL/RELA Interactions with deltaNp63alpha Dysregulate NF-kappaB and p73 Target Genes in Head and Neck Cancer

Bryant G. Darnay, University of Texas MD Anderson Cancer Center, USA
New Genetic Lesion Identified in AML Revealed by a Mouse Model for Myeloid-Specific Deletion of TAK1

Jean-Pierre Julien, Université Laval, Canada
TDP-43 Drives NF-kappaB-Mediated Pathogenic Pathways in Amyotrophic Lateral Sclerosis

Alessandra Agresti, San Raffaele Scientific Institute, Italy
Smart Drugs to Counteract NF-kappaB Driven Proliferation in Multiple Myeloma

Brian C. Schaefer, Uniformed Services University, USA
Selective Autophagy of Bcl10 Modulates T Cell Receptor Activation of NF-kappaB – New Targets for Intervention in Lymphocyte Cancers and Lymphocyte Functional Responses

16:30—17:00
Coffee Available

Grand Foyer
17:00—19:30
New Facets of NF-kappaB/IKK Signaling
Meeting has ended...abstracts no longer viewable online.

Sea to Sky C
* Michael J. Eck, Dana Farber Cancer Institute, USA

Claus Scheidereit, Max Delbrück Center for Molecular Medicine, Germany
NF-kappaB and DNA Damage

David Wallach, Weizmann Institute of Science, Israel
The ‘Apoptotic’ Caspases as Regulators of Inflammation: New Lessons about Caspase-8 Function

Dongsheng Cai, Albert Einstein College of Medicine, USA
Brain NF-kappaB and Metabolic Diseases

Daniel Panne, European Molecular Biology Laboratory, France
Short Talk: Structure and Mechanism of Regulation of IKK Kinases

Erin C. Dueber, Genentech, USA
Short Talk: Molecular Basis of TBK1 Activation by Trans-Autophosphorylation

Smarajit Polley, University of California, San Diego, USA
Short Talk: X-Ray Crystal Structure of the Human IKK2 in an Active Conformation


Following Session is for Ubiquitin Signaling (X2)

17:00—19:00
Ubiquitin-Like Modifiers in Signaling
Meeting has ended...abstracts no longer viewable online.

Sea to Sky B
* Agata Smogorzewska, Rockefeller University, USA

* Kay Hofmann, University of Cologne, Germany

Mary C. Dasso, NICHD, National Institutes of Health, USA
Regulation of Ribosome Biogenesis through the deSUMOylating Enzyme SENP3

Eilika Weber-Ban, ETH Zürich, Switzerland
Pupylation – Ubiquitin-Like Pathway in Bacteria

Jon Huibregtse, University of Texas at Austin, USA
Mechanism and Function of ISG15 Conjugation

Minghua Nie, The Scripps Research Institute, USA
Short Talk: A Role for the Cdc48Ufd1-Npl4 Complex in the Function of STUbL

19:30—20:15
Social Hour with Lite Bites

Sea to Sky A
20:00—23:00
Entertainment

Sea to Sky A

FRIDAY, MARCH 23

 
Departure


*Session Chair †Invited, not yet responded.



We gratefully acknowledge support for this conference from:


Directors' Fund


These generous unrestricted gifts allow our Directors to schedule meetings in a wide variety of important areas, many of which are in the early stages of research.

Click here to view all of the donors who support the Directors' Fund.



Keystone Symposia thanks our Sponsor for generously supporting this meeting:

Onyx Pharmaceuticals, Inc.

We gratefully acknowledge the generous grant for this conference provided by:


National Institutes of Health

Grant No. 1R13AI098239-01

The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.


We gratefully acknowledge additional in-kind support for this conference from those foregoing speaker expense reimbursements:



Genentech, Inc.


Millennium Pharmaceuticals, Inc., The Takeda Oncology Company


We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:

EMBO (European Molecular Biology Organization)

Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:


Click here to view more of these organizations


If your organization is interested in joining these entities in support of Keystone Symposia, please contact: Sarah Lavicka, Director of Development, Email: sarahl@keystonesymposia.org,
Phone:+1 970-262-2690

Click here for more information on Industry Support and Recognition Opportunities.

If you are interested in becoming an advertising/marketing in-kind partner, please contact:
Yvonne Psaila, Director, Marketing and Communications, Email: yvonnep@keystonesymposia.org,
Phone:+1 970-262-2676